Pulmonary Function Tests by Spirometry in Patients with Metabolic Syndrome: A Comprehensive Analysis

Abstract

A cohort of 113 participants satisfying the criteria for metabolic syndrome was used in this study to examine the link between metabolic syndrome and pulmonary function as measured by spirometry. The US National Cholesterol Education Programme Adult Treatment Panel III criteria for metabolic syndrome were used to select participants for a cross-sectional study. We gathered and analyzed information on each subject's demographics, metabolic parameters and lung function tests (FEV1, FVC, and FEV1/FVC ratio). The correlations between the elements of the metabolic syndrome, gender, and pulmonary function indicators were evaluated using statistical analysis. There was a wide age range in the study sample, with the 40 to 59 year old age bracket being the most common. Males had a higher prevalence of metabolic syndrome, according to the gender distribution. Males had greater systolic, diastolic, triglyceride, and fasting blood glucose levels than females, as well as lower levels of high-density lipoprotein cholesterol, among other symptoms of the metabolic syndrome. A sizable number of the individuals had abnormal pulmonary function, with a mixed obstructive and restrictive pattern being the most common. The number of metabolic syndrome components and pulmonary impairment were found to be significantly correlated. The strong link between metabolic syndrome and pulmonary dysfunction is shown in this study, underscoring the significance of early detection and therapy of metabolic syndrome, especially in people with impaired pulmonary function. To enhance the metabolic and pulmonary health of this population, comprehensive lifestyle treatments should be taken into consideration.